Pierce Protease and Phosphatase Inhibitor Mini Tablets,EDTA-free - Citations

Pierce Protease and Phosphatase Inhibitor Mini Tablets,EDTA-free - Citations

View additional product information for Pierce Protease and Phosphatase Inhibitor Mini Tablets,EDTA-free - Citations (A32961)

Showing 4 product Citations

Citations & References
Abstract
Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer.
AuthorsRobles-Oteíza C,Hastings K,Choi J,Sirois I,Ravi A,Expósito F,de Miguel F,Knight JR,López-Giráldez F,Choi H,Socci ND,Merghoub T,Awad M,Getz G,Gainor J,Hellmann MD,Caron É,Kaech SM,Politi K
JournalThe Journal of experimental medicine
PubMed ID39585348
Despite the established use of immune checkpoint inhibitors (ICIs) to treat non-small cell lung cancer (NSCLC), only a subset of patients benefit from treatment and ∼50% of patients whose tumors respond eventually develop acquired resistance (AR). To identify novel drivers of AR, we generated murine Msh2 knock-out (KO) lung tumors ... More
Bioorthogonal Conjugation-Assisted Purification Method for Profiling Cell Surface Proteome.
AuthorsLiu G,Choi MH,Ma H,Guo X,Lo PC,Kim J,Zhang L
JournalAnalytical chemistry
PubMed ID35019258
Surface biotinylation has been widely adapted in profiling the cellular proteome associated with the plasma membrane. However, the workflow is subject to interference from the cytoplasmic biotin-associated proteins that compete for streptavidin-binding during purification. Here we established a bioorthogonal conjugation-assisted purification (BCAP) workflow that utilizes the Staudinger chemoselective ligation to ... More
Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer
AuthorsRobles-Oteíza C, Hastings K, Choi J, Sirois I, Ravi A, Expósito F, de Miguel F, Knight JR, López-Giráldez F, Choi H, Socci ND, Merghoub T, Awad M, Getz G, Gainor J, Hellmann MD, Caron É, Kaech SM, Politi K.
JournalJ Exp Med
PubMed ID39585348
Despite the established use of immune checkpoint inhibitors (ICIs) to treat non-small cell lung cancer (NSCLC), only a subset of patients benefit from treatment and ∼50% of patients whose tumors respond eventually develop acquired resistance (AR). To identify novel drivers of AR, we generated murine Msh2 knock-out (KO) lung tumors ... More
Mitochondria dysregulation contributes to secondary neurodegeneration progression post-contusion injury in human 3D in vitro triculture brain tissue model.
AuthorsLiaudanskaya V,Fiore NJ,Zhang Y,Milton Y,Kelly MF,Coe M,Barreiro A,Rose VK,Shapiro MR,Mullis AS,Shevzov-Zebrun A,Blurton-Jones M,Whalen MJ,Symes AJ,Georgakoudi I,Nieland TJF,Kaplan DL
JournalCell death & disease
PubMed ID37537168
Traumatic Brain injury-induced disturbances in mitochondrial fission-and-fusion dynamics have been linked to the onset and propagation of neuroinflammation and neurodegeneration. However, cell-type-specific contributions and crosstalk between neurons, microglia, and astrocytes in mitochondria-driven neurodegeneration after brain injury remain undefined. We developed a human three-dimensional in vitro triculture tissue model of a ... More